Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Transpl Immunol ; 78: 101838, 2023 06.
Article in English | MEDLINE | ID: mdl-37085124

ABSTRACT

INTRODUCTION: Solid organ transplant recipients (SOTRs) are susceptible to various dermatological complications caused by long-term immunosuppressive therapy. Of these complications, viral infections are noteworthy because of their high prevalence and the potential morbidity associated with viral carcinogenesis. OBJECTIVES: To evaluate the occurrence of cutaneous viral infections in SOTRs and their correlation with clinical features, transplant type, and the length and intensity of immunosuppressive therapy. METHODS: This retrospective cohort study included SOTRs followed up at the Department of Dermatology in a tertiary hospital. The outcomes analyzed were the occurrence of cutaneous viral infections, including human papillomavirus (HPV) infection, herpes simplex, herpes zoster, molluscum contagiosum, Merkel cell carcinoma, Kaposi's sarcoma, and cytomegalovirus, and the occurrence of HPV-related neoplasms. Clinical variables, such as length and intensity of immunosuppression, type of transplanted organ, and comorbidities, were analyzed as possible risk factors for cutaneous viral infections in SOTRs. RESULTS: A total of 528 SOTRs were included in this study, among which 53.8% had one or more viral infections. Of these, 10% developed a virus-associated malignancy (HPV-associated carcinoma, Merkel cell carcinoma, or Kaposi's sarcoma). The higher risk of viral infections among SOTRs was associated with cyclosporine intake (1.40-fold higher risk) and younger age at transplantation. The use of an immunosuppressive regimen, including additional drugs, was associated with a higher risk of genital HPV infection (1.50-fold higher risk for each incremental drug). CONCLUSIONS: The occurrence of cutaneous viral infections in SOTRs is directly associated with the duration and intensity of immunosuppressive therapy. Patients at higher risk were those taking drugs with a stronger impact on cellular immunity and/or those on an immunosuppressive regimen comprising various drugs.


Subject(s)
Organ Transplantation , Papillomavirus Infections , Sarcoma, Kaposi , Virus Diseases , Humans , Organ Transplantation/adverse effects , Sarcoma, Kaposi/epidemiology , Sarcoma, Kaposi/chemically induced , Retrospective Studies , Papillomavirus Infections/epidemiology , Papillomavirus Infections/chemically induced , Papillomavirus Infections/complications , Virus Diseases/complications , Immunosuppressive Agents/adverse effects , Transplant Recipients
2.
Dermatol Online J ; 27(2)2021 Feb 15.
Article in English | MEDLINE | ID: mdl-33818984

ABSTRACT

Epidermodysplasia verruciformis is a rare genodermatosis associated with mutations in the EVER1/TMC6 and EVER2/TMC8 genes. The inheritance is considered to be autosomal recessive, but reports suggesting an autosomal dominant inheritance indicate disease genetic heterogeneity. Its onset occurs in early childhood and presents as a combination of pityriasis versicolor-like, flat wart-like and seborrheic keratosis-like lesions, with a potential for malignant transformation, mainly squamous cell carcinoma.


Subject(s)
Epidermodysplasia Verruciformis/genetics , Female , Humans , Inheritance Patterns , Male , Middle Aged , Young Adult
3.
Transpl Immunol ; 64: 101355, 2021 02.
Article in English | MEDLINE | ID: mdl-33264680

ABSTRACT

Solid organ transplant recipients (SOTRs) are susceptible to various cutaneous side effects as a consequence of long-term immunosuppressive therapy. Skin cancers and infections are well-studied complications that can cause death and/or allograft rejection. Other cutaneous drug reactions, such as inflammatory manifestations, have a high prevalence but are rarely studied. We analyzed these manifestations' prevalence and their association with immunosuppressants in transplant recipients from a Brazilian tertiary center. Among 532 SOTRs followed at our dermatology clinic, 60 (11.3%) developed some cutaneous adverse reactions to the immunosuppressants, with a median age at transplantation of 50.5 years and a median life span posttransplantation of seven years. Acneiform eruption was the most common drug reaction found (21 patients, 30.4%), followed by diffuse non-scarring alopecia (16 patients, 23.1%), lymphedema (10 patients, 14.5%), gingival hyperplasia (7 patients, 10.1%), hypertrichosis (6 patients, 8.7%) and sebaceous hyperplasia (9 patients, 13.1%). Adequate immunosuppression is an essential prerequisite for successful organ transplantation. In the immediate post-transplant period, significant immunosuppression is needed, but after that, the complications of excessive immunosuppression outweigh the risk of organ rejection. SORTs may present with a broad spectrum of inflammatory and cosmetic findings due to immunosuppressants that can impair life quality.


Subject(s)
Acneiform Eruptions/epidemiology , Alopecia/epidemiology , Drug-Related Side Effects and Adverse Reactions/epidemiology , Graft Rejection/drug therapy , Immunosuppressive Agents/adverse effects , Lymphedema/epidemiology , Organ Transplantation , Skin/pathology , Acneiform Eruptions/etiology , Adolescent , Adult , Aged , Brazil/epidemiology , Female , Humans , Immunosuppressive Agents/therapeutic use , Male , Middle Aged , Skin/drug effects , Young Adult
4.
Sci Rep ; 10(1): 9268, 2020 06 09.
Article in English | MEDLINE | ID: mdl-32518268

ABSTRACT

Epidermodysplasia verruciformis (EV) is a genodermatosis related to human beta-papillomavirus (beta-HPV), with a high risk of cutaneous squamous cell carcinoma (cSCC). Claudins are transmembrane proteins expressed in epithelia and may be altered during carcinogenesis. For a better understanding of the role of beta-HPV in cutaneous carcinogenesis, this claudin expression study was conducted on lesions of patients with and without EV. In this study, claudins-1, -2, -3, -4, -5, -7 and -11 expressions were analyzed by applying the immunohistochemistry technique, in samples of 108 normal skin, 39 flat warts and 174 cSCC. The cSCC samples were organized in tissue microarrays. We found that claudin-1 and claudin-3 focal expressions were associated with cSCC (p < 0.001), and claudin-2 focal or negative expression with flat wart (p < 0.001), in EV and NEV (non-EV) groups. For claudin-5, EV group showed a lower chance of focal and negative expression (p < 0.001), and its negative expression was associated with flat wart (p < 0.001) and lower mean age (p < 0.001). Claudins-4, -7 and -11 showed a diffuse expression in almost all studied samples. Our findings suggest that claudin-5 increased expression observed on normal skin, flat wart and cSCC showed association with EV. Claudin-1 and -3 down expression were also observed, but they could not be related to beta-HPV infection.


Subject(s)
Carcinoma, Squamous Cell/metabolism , Claudins/metabolism , Epidermodysplasia Verruciformis/metabolism , Skin Neoplasms/metabolism , Adolescent , Adult , Aged , Aged, 80 and over , Carcinoma, Squamous Cell/pathology , Child , Child, Preschool , Epidermodysplasia Verruciformis/pathology , Female , Humans , Male , Middle Aged , Skin Neoplasms/pathology , Young Adult
5.
An Bras Dermatol ; 91(1): 89-92, 2016.
Article in English | MEDLINE | ID: mdl-26982786

ABSTRACT

Phaeohyphomycosis is an infection caused by a filamentous fungus that contains pigment melanin in its cell wall. We report two cases caused by Exophiala sp. emphasizing the clinical variability of the disease, as well as diagnostic and therapeutic difficulties of this opportunistic infection in immunosuppressed patients (kidney transplant).


Subject(s)
Exophiala/isolation & purification , Kidney Transplantation/adverse effects , Phaeohyphomycosis/pathology , Antifungal Agents/therapeutic use , Humans , Immunocompromised Host , Immunosuppressive Agents/adverse effects , Male , Middle Aged , Opportunistic Infections/immunology , Opportunistic Infections/pathology , Opportunistic Infections/therapy , Phaeohyphomycosis/immunology , Phaeohyphomycosis/therapy , Skin/pathology
SELECTION OF CITATIONS
SEARCH DETAIL
...